Barclays’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.22M | Buy |
839,894
+474,859
| +130% | +$1.25M | ﹤0.01% | 2161 |
|
2025
Q1 | $1.1M | Sell |
365,035
-31,449
| -8% | -$94.7K | ﹤0.01% | 2392 |
|
2024
Q4 | $1.02M | Buy |
396,484
+35,448
| +10% | +$90.7K | ﹤0.01% | 2629 |
|
2024
Q3 | $1.34M | Buy |
361,036
+202,248
| +127% | +$753K | ﹤0.01% | 2437 |
|
2024
Q2 | $1M | Sell |
158,788
-226,881
| -59% | -$1.43M | ﹤0.01% | 2116 |
|
2024
Q1 | $2.07M | Sell |
385,669
-93,876
| -20% | -$504K | ﹤0.01% | 1918 |
|
2023
Q4 | $2.41M | Buy |
479,545
+435,172
| +981% | +$2.18M | ﹤0.01% | 2036 |
|
2023
Q3 | $75K | Sell |
44,373
-16,096
| -27% | -$27.2K | ﹤0.01% | 3429 |
|
2023
Q2 | $168K | Buy |
60,469
+19,181
| +46% | +$53.3K | ﹤0.01% | 3172 |
|
2023
Q1 | $75K | Sell |
41,288
-215,077
| -84% | -$391K | ﹤0.01% | 3661 |
|
2022
Q4 | $1.3M | Buy |
256,365
+3,335
| +1% | +$16.9K | ﹤0.01% | 1929 |
|
2022
Q3 | $1.26M | Buy |
253,030
+242,167
| +2,229% | +$1.2M | ﹤0.01% | 1958 |
|
2022
Q2 | $40K | Sell |
10,863
-778
| -7% | -$2.87K | ﹤0.01% | 3814 |
|
2022
Q1 | $66K | Buy |
+11,641
| New | +$66K | ﹤0.01% | 3870 |
|
2021
Q1 | – | Sell |
-37,686
| Closed | -$503K | – | 3924 |
|
2020
Q4 | $503K | Sell |
37,686
-18,316
| -33% | -$244K | ﹤0.01% | 2316 |
|
2020
Q3 | $388K | Buy |
56,002
+1,446
| +3% | +$10K | ﹤0.01% | 2431 |
|
2020
Q2 | $670K | Buy |
54,556
+54,516
| +136,290% | +$670K | ﹤0.01% | 2159 |
|
2020
Q1 | $0 | Sell |
40
-42
| -51% | – | ﹤0.01% | 3768 |
|
2019
Q4 | $0 | Hold |
82
| – | – | ﹤0.01% | 4022 |
|
2019
Q3 | $0 | Sell |
82
-2,062
| -96% | – | ﹤0.01% | 4245 |
|
2019
Q2 | $3K | Sell |
2,144
-6,629
| -76% | -$9.28K | ﹤0.01% | 4114 |
|
2019
Q1 | $14K | Buy |
8,773
+7,814
| +815% | +$12.5K | ﹤0.01% | 3965 |
|
2018
Q4 | $1K | Sell |
959
-10,481
| -92% | -$10.9K | ﹤0.01% | 4000 |
|
2018
Q3 | $42K | Buy |
11,440
+9,332
| +443% | +$34.3K | ﹤0.01% | 3782 |
|
2018
Q2 | $6K | Sell |
2,108
-11,439
| -84% | -$32.6K | ﹤0.01% | 3984 |
|
2018
Q1 | $52K | Sell |
13,547
-14,539
| -52% | -$55.8K | ﹤0.01% | 3488 |
|
2017
Q4 | $126K | Buy |
28,086
+1,584
| +6% | +$7.11K | ﹤0.01% | 2888 |
|
2017
Q3 | $145K | Buy |
26,502
+1,112
| +4% | +$6.08K | ﹤0.01% | 2541 |
|
2017
Q2 | $193K | Sell |
25,390
-60,967
| -71% | -$463K | ﹤0.01% | 2452 |
|
2017
Q1 | $306K | Buy |
86,357
+83,192
| +2,628% | +$295K | ﹤0.01% | 2250 |
|
2016
Q4 | $18K | Sell |
3,165
-594
| -16% | -$3.38K | ﹤0.01% | 3117 |
|
2016
Q3 | $30K | Buy |
3,759
+2,397
| +176% | +$19.1K | ﹤0.01% | 2908 |
|
2016
Q2 | $8K | Buy |
1,362
+801
| +143% | +$4.71K | ﹤0.01% | 3040 |
|
2016
Q1 | $4K | Sell |
561
-973
| -63% | -$6.94K | ﹤0.01% | 3094 |
|
2015
Q4 | $26K | Buy |
+1,534
| New | +$26K | ﹤0.01% | 2650 |
|